m6A修饰及其在妇科癌症中的临床应用
Chavi Ahlawat1, Priya Yadav1, Nikita Balhara1
1Department of Genetics, Maharshi Dayanand University, Rohtak, Haryana, 124001, India.
Apoptosis : an international journal on programmed cell death
|January 10, 2026
概括
在妇科癌症中,N6-甲基氨酸 (m6A) RNA 修饰至关重要,影响瘤生长和治疗反应. 作为诊断和预后生物标志物,m6A调节剂显示出有前途.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- N6-甲基氨酸 (m6A) RNA修饰是影响基因表达的关键表观遗传机制.
- 调节m6A调节者的失调与各种癌症的发展和进展有关,包括妇科恶性瘤.
研究的目的:
- 审查m6ARNA修饰调节器在妇科癌症中的多方面的作用.
- 在这种情况下,批判性地评估m6A调节剂的生物标志物和临床潜力.
主要方法:
- 在妇科癌症中对m6ARNA修饰的文献综述.
- 分析了m6A"写字器"",擦拭器"和"阅读器"的功能.
- 评估m6A调节器的诊断,预后和预测意义.
主要成果:
- m6A调节器 (写字器,擦拭器,阅读器) 在妇科癌症中显著影响瘤的发病,进展和治疗阻力.
- 这些调节器调节基本的RNA代谢过程,如拼接,稳定性,翻译和降解.
- 由于m6A调节器活性,观察到瘤和瘤抑制途径的改变.
结论:
- m6A调节器在妇科癌症的发病过程中起着关键作用.
- m6A调节剂作为诊断,预后和预测妇科癌症治疗反应的生物标志物具有显著的潜力.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K


